In-vitro and in-vivo illumination

In Vitro and In Vivo illumination

Modulight provides a versatile and comprehensive product family for in-vitro and in-vivo illumination. Modulight lasers are used in many cell research laboratories worldwide to study photodynamic therapy (PDT). PDT utilizes photosensitizers that can be activated with specifically designed light sources – reactive oxygen is created at the target due to light activation.

Photosensitizers are also used in targeted drug delivery, and light activation is used for releasing the drug from the cargo. The PDT is on the verge of bringing another revolutionizing tool to be used in the treatment of glioblastoma, uveal melanoma, bile duct, pancreatic, and many other cancers.

Modulight’s in-vitro and in-vivo product family enables illumination of anything. We make lasers with variety of wavelengths, ranging from 400 to 2000 nm. Thus, we can support the research of all existing photosensitizers.

Our product offering: from In Vitro to Clinic with Modulight lasers

In Vitro
In Vitro
In Vitro
In Vivo
Clinical
Clinical

Application Notes and Articles by Our Customers

Development of heat shock protein 90-targeted PDT for inflammatory breast cancer

Customer case Research by: Duke University, founded in 1924, is one of the leading and wealthiest private research universities in the USA. The most notable Duke alumni is President Richard Nixon. Research at Duke University has been awarded with several Nobel prizes in recent years for groundbreaking discoveries in biochemistry and medicine, such as G-protein coupled receptors, DNA mismatch repair, and cellular regulation of hypoxia. Modulight products: ML8500, ML7710 (665 nm, 689 nm, 750 nm) Laser use: Heat shock protein 90-targeted PDT for breast cancer Continue reading →

In vitro illumination using ML8500: osmium-based anticancer photosensitizer with highest hypoxic activity reported to date

Basic Info of the Study Research by: University of Texas at Arlington, US. One of the leading groups in photoactive drug discovery. Developed first clinical-level rubidium-based PS (TLD-1433), now in Theralase-sponsored Phase 2 trials for bladder cancer. Modulight products: ML8500 (445 nm, 525 nm, 630 nm, 753 nm, 810 nm) Laser use: Photoactive drug discovery Dr. Sherri McFarland (see her referral of Modulight) Research topics: Medicinal inorganic chemistry and drug discovery. Special interest in synthesis of novel transition metal complexes and studying their interactions with light Continue reading →

Fully automated illumination study series for modern cancer drug development

Fully automated illumination study series for modern cancer drug development In vitro cell viability and dose escalation study for developing photosensitive or photoactivated drugs using Modulight ML7710 medical laser and ML8500 automated illumination system.   STUDY PLAN The goal was to investigate the effect of irradiance and light dose on a cancer cell line while keeping the photosensitive drug dosing constant. The well-by-well dose escalation plan was done in tabular format. TARGET Cancer cell line incubated at 37°C in acidic culture DRUG TYPE Photosensitive or Continue reading →

Watch video about Modulight's In Vitro / In Vivo Solutions

Slide
PlayPlay

Essential products for in vivo, in vitro, and preclinical applications

ML8500 – automated biomedical illumination device – provides targeted illumination for microplates. Each well is automatically and sequentially illuminated with a specific dose, irradiance and wavelength. Environmental parameters, like carbon dioxide content and temperature, can be adjusted. Optional fluorescence monitoring and cell imaging are also available. ML8500 supports various microplates (24/96/384/1536) and petri dishes. Illumination programs can be created remotely, and collecting data from the cloud can be conveniently done from the office – no need to control the illumination at the lab. Cloud connection enables also the remote support, service, and upgrades.

ML7710 is the most versatile oncology laser system for PDT studies, and the same product can be used for in-vitro/vivo studies and clinical therapies (CE mark, FDA approval for some combination therapies). The ML7710 is a cost-effective solution for long-term study plan including pre-clinical and clinical phases – using the same device from first phase studies to clinical tests makes regulatory work faster. The ML7710 is used already in many clinics and in well-known cancer centers worldwide. We provide internet connectivity, remote diagnostics, cloud services, and low-cost upgrades.

Modulight Illumination Kit is a series of accessories that enable uniform, parallel illumination of petri dishes and well plates. The whole sample plate is illuminated simultaneously in a specially designed illumination chamber. The laser light source can be an ML7710, or very compact but powerful ML6500 and ML6600 laser modules. ML6500 enables the use of one wavelength and ML6600 up to 3 wavelengths.  These laser sources can be used together with different light delivery options, e.g., SMA connected fiber with a frontal diffuser at the end. Most popular option among in vitro studies is to have our Illumination Kit sample stage that enables illumination of the well plate.

Modulight provides also many different and customized sample stage designs which can be tailored to fit any illumination target. We provide support for dose calculation and calibration, and our lasers have simple graphical user interfaces or they can be controlled from the computer. Products are supported with full suite of services from calibration to on-site training.

Illumination solution can be customized to your needs:

  • Wavelength can be selected between 400 – 2000 nm
  • Irradiance and dose can be adjusted
  • Different sample stages supporting the use of microplates, petri dishes, and possibility for customized
  • Handpiece enables in vivo subcutaneous illumination, option for spot size adjustment
  • We provide many different medical fiber options
  • Controlled and repeatable illumination, support for dose calculation
  • Possibility to use 1-8 different wavelengths
  • Pulsing possible in ms – µs range
  • On-site training
  • Regular calibrations and device support

In-vitro and in-vivo customer referrals

Poul Martin Bendix, PhD, Associate Professor at Niels Bohr Institute

Sherri McFarland, PhD, Professor at University of Texas at Arlington (Formerly Professor at The University of North Carolina at Greensboro)

Drop us a line and we'll help you find a solution!

    First name *

    Family name *

    Company or affiliation *